Hold Dishman Pharma, tgt of Rs 323: India Capital Markets

5292 Investors following Dishman Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Hold Dishman Pharma, tgt of Rs 323: India Capital Markets

India Capital Markets has recommended a hold rating on Dishman Pharmaceuticals & Chemicals with a target of Rs 323 in its September 29, 2008 research report.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Buy Jubilant Org, target of Rs 397: India Capital Markets Buy IVRCL Infrastructure, target of Rs 308: P Lilladher Buy Dish TV, target of Rs 48: Kotak Institution Buy Pyramid Saimira Theatre: Keynote Buy Dr Reddys Labs, target of Rs 650: J.P.Morgan ALSO READ See previous views by India Capital Markets See what other Experts & Brokerages are saying about Dishman Pharma See messages about Dishman Pharma Dishman Pharma BSE | NSE 25/05/12 Are Mutual Funds betting on Dishman Pharma?

India Capital Markets has recommended a hold rating on Dishman Pharmaceuticals & Chemicals with a target of Rs 323 in its September 29, 2008 research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......